| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1151 |
| Trial ID | NCT00003167 |
| Disease | Bladder Cancer |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | INGN-201|Advexin|AdV5.CMV-p53 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Trial of Intravesical Ad-p53 Treatment in Locally Advanced and Metastatic Bladder Cancer |
| Year | 1999 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | NCI-2012-02261|MDA-DM-96172|R21CA076233|CDR0000065968 |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||
|
|||||||